TriangleNCT02709512 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- false
- restriction Type
- LTE60
- restrictive Agreement
- true
- limitations And Caveats
- description
- Enrollment stopped early at the recommendation of the DSMB due to interim analysis positive results and because of slow study enrollment related to an evolving treatment landscape for MPM and the COVID-19 pandemic.
- point Of Contact
- mlanglois@polarispharma.com
- organization
- Polaris Pharmaceuitcals Inc
- phone
- 858-452-6688
- phone Ext
- 161
- title
- Dr. Mirla Langlois
Complete source fields
- certain Agreement
- pi Sponsor Employee
- false
- restriction Type
- LTE60
- restrictive Agreement
- true
- limitations And Caveats
- description
- Enrollment stopped early at the recommendation of the DSMB due to interim analysis positive results and because of slow study enrollment related to an evolving treatment landscape for MPM and the COVID-19 pandemic.
- point Of Contact
- mlanglois@polarispharma.com
- organization
- Polaris Pharmaceuitcals Inc
- phone
- 858-452-6688
- phone Ext
- 161
- title
- Dr. Mirla Langlois
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice